Macrophage and Adipocyte Mitochondrial Dysfunction in Obesity-Induced Metabolic Diseases

다국어 초록 (Multilingual Abstract)

Obesity is one of major health burdens of modern society as it contributes to the growing prevalence of its related comorbidities, such as diabetes, cardiovascular diseases, and some cancers. A series of innate immune cells, especially macrophages, and adipocytes have been implicated in the pathogenesis of obesity. Mitochondrial dysfunction, which is induced by obesity, are critical mediators in initiating inflammation in macrophages and adipocytes, and subsequent systemic insulin resistance.
In this review, we discuss new findings on how obesity impairs mitochondrial function in macrophages and adipocytes and how this dysfunction contributes to obesity and its comorbidities. We also summarize drugs that treat metabolic diseases by targeting mitochondrial dysfunction.

참고문헌 (Reference)

1 Ablasser A, "cGAS in action: expanding roles in immunity and inflammation" 363 : eaat8657-, 2019

2 Kwon EY, "Time-course microarrays reveal early activation of the immune transcriptome and adipokine dysregulation leads to fibrosis in visceral adipose depots during diet-induced obesity" 13 : 450-, 2012

3 Yki-Järvinen H, "Thiazolidinediones" 351 : 1106-1118, 2004

4 O'Connell J, "The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity" 5 : e9997-, 2010

5 Bai J, "The cGAS-cGAMP-STING pathway : a molecular link between immunity and metabolism" 68 : 1099-1108, 2019

6 구철룡, "The Effects of High Fat Diet and Resveratrol on Mitochondrial Activity of Brown Adipocytes" 대한내분비학회 31 (31): 328-335, 2016

7 Lahera V, "Role of mitochondrial dysfunction in hypertension and obesity" 19 : 11-, 2017

8 강예은, "Regulation of Systemic Glucose Homeostasis by T Helper Type 2 Cytokines" 대한당뇨병학회 43 (43): 549-559, 2019

9 Chen L, "Reduction of mitochondrial H2O2 by overexpressing peroxiredoxin 3 improves glucose tolerance in mice" 7 : 866-878, 2008

10 Jung SB, "Reduced oxidative capacity in macrophages results in systemic insulin resistance" 9 : 1551-, 2018

11 Sliter DA, "Parkin and PINK1 mitigate STING-induced inflammation" 561 : 258-262, 2018

12 Cui C, "PINK1-Parkin alleviates metabolic stress induced by obesity in adipose tissue and in 3T3-L1 preadipocytes" 498 : 445-452, 2018

13 Zhang P, "Oxidative stress and diabetes: antioxidative strategies" 2020

14 Mouton AJ, "Obesity, hypertension, and cardiac dysfunction: novel roles of immunometabolism in macrophage activation and inflammation" 126 : 789-806, 2020

15 World Health Organization, "Obesity and overweight" World Health Organization

16 Khan MSH, "Obesity and diabetes mediated chronic inflammation : a potential biomarker in Alzheimer's disease" 10 : 42-, 2020

17 Zhou Y, "Obesity and diabetes as highrisk factors for severe coronavirus disease 2019 (Covid-19)" 2020

18 Petrakis D, "Obesity - a risk factor for increased COVID-19prevalence, severity and lethality (review)" 22 : 9-19, 2020

19 Jang JE, "Nitric oxide produced by macrophages inhibits adipocyte differentiation and promotes profibrogenic responses in preadipocytes to induce adipose tissue fibrosis" 65 : 2516-2528, 2016

20 Xu J, "NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation" 125 : 1579-1590, 2015

21 Ko MS, "Mitophagy deficiency increases NLRP3 to induce brown fat dysfunction in mice" 2020

22 Demine S, "Mitochondrial uncoupling : a key controller of biological processes in physiology and diseases" 8 : 795-, 2019

23 Bai J, "Mitochondrial stress-activated cGAS-STING pathway inhibits thermogenic program and contributes to overnutritioninduced obesity in mice" 3 : 257-, 2020

24 Zezina E, "Mitochondrial fragmentation in human macrophages attenuates palmitate-induced inflammatory responses" 1863 : 433-446, 2018

25 Jheng HF, "Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle" 32 : 309-319, 2012

26 Bournat JC, "Mitochondrial dysfunction in obesity" 17 : 446-452, 2010

27 Prasun P, "Mitochondrial dysfunction in metabolic syndrome" 1866 : 165838-, 2020

28 Chiurazzi M, "Mitochondrial dynamics and microglia as new targets in metabolism regulation" 21 : 3450-, 2020

29 우창윤, "Mitochondrial Dysfunction in Adipocytes as a Primary Cause of Adipose Tissue Inflammation" 대한당뇨병학회 43 (43): 247-256, 2019

30 Kim JD, "Microglial UCP2 mediates inflammation and obesity induced by high-fat feeding" 30 : 952-962.e5, 2019

31 Kulkarni SS, "Mfn1 deficiency in the liver protects against diet-induced insulin resistance and enhances the hypoglycemic effect of metformin" 65 : 3552-3560, 2016

32 Kelly B, "Metformin inhibits the production of reactive oxygen species from NADH : Ubiquinone oxidoreductase to limit induction of interleukin-1β(IL-1β)and boosts interleukin-10(IL-10)in lipopolysaccharide(LPS)-activated macrophages" 290 : 20348-20359, 2015

33 Li A, "Metformin and resveratrol inhibit Drp1-mediated mitochondrial fission and prevent ER stress-associated NLRP3 inflammasome activation in the adipose tissue of diabetic mice" 434 : 36-47, 2016

34 Ursini F, "Metformin and autoimmunity : a"new deal"of an old drug" 9 : 1236-, 2018

35 Coats BR, "Metabolically activated adipose tissue macrophages perform detrimental and beneficial functions during diet-induced obesity" 20 : 3149-3161, 2017

36 Tiwari P, "Metabolically activated adipose tissue macrophages link obesity to triple-negative breast cancer" 216 : 1345-1358, 2019

37 Boscá L, "Metabolic signatures linked to macrophage polarization : from glucose metabolism to oxidative phosphorylation" 43 : 740-744, 2015

38 Cummins TD, "Metabolic remodeling of white adipose tissue in obesity" 307 : E262-E277, 2014

39 Kratz M, "Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages" 20 : 614-625, 2014

40 Okla M, "Inhibitory effects of toll-like receptor 4, NLRP3 inflammasome, and interleukin-1β on white adipocyte browning" 41 : 626-642, 2018

41 Liu R, "Impaired mitochondrial dynamics and bioenergetics in diabetic skeletal muscle" 9 : e92810-, 2014

42 Heinonen S, "Impaired mitochondrial biogenesis in adipose tissue in acquired obesity" 64 : 3135-3145, 2015

43 O'Neill LA, "Immunometabolism governs dendritic cell and macrophage function" 213 : 15-23, 2016

44 Feng J, "IL-25 stimulates M2 macrophage polarization and thereby promotes mitochondrial respiratory capacity and lipolysis in adipose tissues against obesity" 15 : 493-505, 2018

45 Wen H, "Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling" 12 : 408-415, 2011

46 Pan J, "Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release" 332 : 111-120, 2018

47 Zhou Z, "Estrogen receptor α controls metabolism in white and brown adipocytes by regulating Polg1 and mitochondrial remodeling" 12 : eaax8096-, 2020

48 Koh EH, "Essential role of mitochondrial function in adiponectin synthesis in adipocytes" 56 : 2973-2981, 2007

49 Inzucchi SE, "Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus" 338 : 867-872, 1998

50 Bai J, "DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway" 114 : 12196-12201, 2017

51 Kabra UD, "Direct substrate delivery into mitochondrial fission-deficient pancreatic islets rescues insulin secretion" 66 : 1247-1257, 2017

52 Dalmas E, "Defining macrophage phenotype and function in adipose tissue" 32 : 307-314, 2011

53 Wu H, "Deficiency of mitophagy receptor FUNDC1 impairs mitochondrial quality and aggravates dietary-induced obesity and metabolic syndrome" 15 : 1882-1898, 2019

54 Zatterale F, "Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes" 10 : 1607-, 2020

55 Altshuler-Keylin S, "Beige adipocyte maintenance is regulated by autophagy-induced mitochondrial clearance" 24 : 402-419, 2016

56 Mizushima N, "Autophagy : process and function" 21 : 2861-2873, 2007

57 Prasad M, "Autoimmune responses and inflammation in type 2 diabetes" 107 : 739-748, 2020

58 Lee YS, "An integrated view of immunometabolism" 172 : 22-40, 2018

59 Zhang Y, "Adipose-specific deletion of autophagy-related gene 7(atg7)in mice reveals a role in adipogenesis" 106 : 19860-19865, 2009

60 Catrysse L, "Adipose tissue macrophages and their polarization in health and obesity" 330 : 114-119, 2018

61 Hoffstedt J, "Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance" 89 : 1391-1396, 2004

62 Wang ZV, "Adiponectin, the past two decades" 8 : 93-100, 2016

63 Ruan H, "Adiponectin signaling and function in insulin target tissues" 8 : 101-109, 2016

64 Luo Y, "Adiponectin : a versatile player of innate immunity" 8 : 120-128, 2016

65 Guilherme A, "Adipocyte dysfunctions linking obesity to insulin resistance and type 2diabetes" 9 : 367-377, 2008

66 Bae J, "Activation of pattern recognition receptors in brown adipocytes induces inflammation and suppresses uncoupling protein 1 expression and mitochondrial respiration" 306 : C918-C930, 2014

67 Lin HY, "Abrogation of toll-like receptor 4 mitigates obesityinduced oxidative stress, proinflammation, and insulin resistance through metabolic reprogramming of mitochondria in adipose tissue" 33 : 66-86, 2020

68 Piao L, "A novel plasminogen activator inhibitor-1 inhibitor, TM5441, protects against highfat diet-induced obesity and adipocyte injury in mice" 173 : 2622-2632, 2016

69 Netea MG, "A guiding map for inflammation" 18 : 826-831, 2017